- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs for Hodgkin's lymphoma
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 15, Issue 4, Pages 585-595
Publisher
Informa Healthcare
Online
2010-07-15
DOI
10.1517/14728214.2010.505602
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Late Effects of Hodgkin’s Disease and Its Treatment
- (2010) Andrea K. Ng et al. CANCER JOURNAL
- Lymphoma stem cells: enough evidence to support their existence?
- (2010) J. A. Martinez-Climent et al. HAEMATOLOGICA
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
- (2010) Donatella Aldinucci et al. JOURNAL OF PATHOLOGY
- Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation
- (2010) Andrea Gallamini et al. LEUKEMIA & LYMPHOMA
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Approaches to the Management of Pediatric Hodgkin Lymphoma
- (2010) Jennifer Freed et al. PEDIATRIC DRUGS
- Stem cells in Hodgkin lymphoma?
- (2009) R. D. Gascoyne BLOOD
- Circulating clonotypic B cells in classic Hodgkin lymphoma
- (2009) R. J. Jones et al. BLOOD
- A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2009) Andres Forero-Torres et al. BRITISH JOURNAL OF HAEMATOLOGY
- Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma
- (2009) Alison J. Moskowitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma
- (2009) Boris Böll et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Histone deacetylase inhibitors as anti-neoplastic agents
- (2009) Nicolas Batty et al. CANCER LETTERS
- In vitro and In vivo Characterization of MDX-1401 for Therapy of Malignant Lymphoma
- (2009) P. M. Cardarelli et al. CLINICAL CANCER RESEARCH
- Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF- B and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell-Mediated Cytotoxicity
- (2009) B. Boll et al. CLINICAL CANCER RESEARCH
- Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future
- (2009) S.J. Proctor et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
- (2009) B. Hirsch et al. CURRENT DRUG TARGETS
- Potent antibody drug conjugates for cancer therapy
- (2009) Peter D Senter CURRENT OPINION IN CHEMICAL BIOLOGY
- Hodgkin's Lymphoma in Adolescents Treated With Adult Protocols: A Report From the German Hodgkin Study Group
- (2009) Dennis A. Eichenauer et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of the Anti-VEGF Monoclonal Antibody Bevacizumab in a Preclinical Model and in Patients With Refractory and Multiple Relapsed Hodgkin Lymphoma
- (2009) Katrin S. Reiners et al. JOURNAL OF IMMUNOTHERAPY
- TNF-α-converting enzyme (TACE/ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species
- (2009) A M Vahdat et al. LEUKEMIA
- Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines
- (2009) Ingo Hartlapp et al. LEUKEMIA RESEARCH
- New treatment strategies for Hodgkin's lymphoma
- (2009) Martin Sebastian Staege et al. LEUKEMIA RESEARCH
- Salvage Therapy in Hodgkin's Lymphoma
- (2009) J. H. Mendler et al. ONCOLOGIST
- Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
- (2009) A. Younes Hematology-American Society of Hematology Education Program
- The 2008 WHO classification of lymphomas: implications for clinical practice and translational research
- (2009) E. S. Jaffe Hematology-American Society of Hematology Education Program
- Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells
- (2008) Karl R.N. Baumforth et al. AMERICAN JOURNAL OF PATHOLOGY
- Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
- (2008) D. Buglio et al. BLOOD
- Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
- (2008) C. Kobe et al. BLOOD
- The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells?
- (2008) M. Janz et al. HAEMATOLOGICA
- Lenalidomide for the Treatment of B-Cell Malignancies
- (2008) Asher A. Chanan-Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma
- (2008) Roger Rautert et al. LEUKEMIA & LYMPHOMA
- Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma
- (2007) Yasuhiro Oki et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More